A June 12 release from the U.S. Office of the Director of National Intelligence (ODNI), led by Tulsi Gabbard, states that a network of more than 40 laboratories in Ukraine may have stored and researched dangerous pathogens. The report alleges these facilities were supported by U.S. biosecurity funding and involved foreign contractors, raising questions about the security of materials including anthrax, plague, tuberculosis, and various hemorrhagic fever viruses.
The ODNI-released materials include a specific map of facilities across Ukraine, identifying three sites in Kyiv, three in Odesa—one of which is labeled as a biological weapons storage site—and additional labs in locations including Lviv, Kharkiv, and Crimea.
Context and Previous Allegations
The release of these materials follows a history of claims made by Gabbard regarding biological research in Ukraine. In March 2022, she circulated a video alleging that U.S.-funded labs in the country were developing biological weapons. At that time, Senator Mitt Romney characterized those claims as “repeating false Russian propaganda,” according to reporting by the New York Times.
Gabbard has faced consistent criticism for positions that align with the narrative of the Russian government, including her assertion that the war in Ukraine could have been avoided had the U.S. and NATO addressed Russia’s “legitimate concerns” regarding the expansion of the Alliance. In May 2026, the director stated that U.S. intelligence was investigating the activities of more than 120 U.S.-funded laboratories located outside of the country.
Implications of the Intelligence Release
The intelligence community previously warned that at least one U.S.-funded laboratory in Ukraine was potentially vulnerable to seizure or damage by Russian forces. The current documentation suggests that these sites were intended to enhance biological protection and provide training for specialists. However, the potential presence of pathogens such as the Ebola, Marburg, and Lassa viruses, alongside SARS and MERS, remains a point of contention.
The release of these specific, albeit disputed, materials underscores a significant shift in how intelligence data is being utilized in the public sphere. When official bodies release information that mirrors prior propaganda narratives, it creates a complex challenge for verification. The primary stake here is the distinction between legitimate, government-funded biosafety cooperation and the unauthorized research of dangerous agents, a line that remains heavily blurred in the current discourse.
Potential Next Steps
Following the publication of these materials, investigative journalist Christo Grozev suggested that the release serves as an information operation intended to benefit the Kremlin. Because the claims involve sensitive intelligence regarding biological agents, international observers may demand further verification or independent audits of the facilities mentioned in the report. It is possible that this documentation will trigger renewed diplomatic debates regarding the oversight of international biological research programs and the transparency of U.S. biosecurity funding.
Frequently Asked Questions
What pathogens were reportedly stored in these laboratories?
According to the ODNI release, the laboratories allegedly stored and studied pathogens including anthrax, plague, tuberculosis, Ebola, Marburg, Lassa, SARS, and MERS.
How many laboratories are mentioned in the report?
The materials describe a network of more than 40 laboratories across various locations in Ukraine, including facilities in Kyiv, Odesa, Lviv, and Dnipro.
What is the official stated purpose of these labs?
The release notes that the facilities were funded under U.S. biosecurity programs, primarily intended for improving biological defense levels and training specialists.
How should the international community verify the nature of biological research facilities during ongoing conflicts?
